Glenmark Therapeutics Inc. has launched Polyethylene Glycol 3350, an over-the-counter product, on March 10, 2025, which competes with MiraLAX that has annual sales of about $555.7 million.
AI Assistant
Glenmark Pharmaceuticals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.